Seeing Is Believing

Currently out of the existing stock ratings of Dana Flanders, 25 are a BUY (59.52%), 15 are a HOLD (35.71%), 2 are a SELL (4.76%).
Analyst Dana Flanders, carries an average stock price target met ratio of 77.6% that have a potential upside of 22.24% achieved within 244 days. Previously, Dana Flanders worked at GUGGENHEIM, GOLDMAN SACHS, JPMORGAN.
Dana Flanders’s has documented 75 price targets and ratings displayed on 16 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VALN, Valneva SE ADR at 08-Sep-2025.
Analyst best performing recommendations are on ANIP (ANI PHARMACEUTICALS).
The best stock recommendation documented was for ANIP (ANI PHARMACEUTICALS) at 9/11/2019. The price target of $76 was fulfilled within 2 days with a profit of $6.36 (9.13%) receiving and performance score of 45.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Dec-2024
$10
$3.67 (57.98%)
$10
25 days ago
(09-Sep-2026)
0/14 (0%)
$4.32 (76.06%)
Sell Since 20-Nov-2023
1 months 13 days ago
(21-Aug-2026)
2/3 (66.67%)
$0.88 (10.84%)
7
Buy Since 11-Apr-2024
$12
$3.47 (40.68%)
$8
1 years 10 months 27 days ago
(07-Nov-2024)
7/11 (63.64%)
$1 (9.09%)
72
Buy Since 13-Sep-2024
$16
$9.67 (152.76%)
$23
2 years 21 days ago
(13-Sep-2024)
10/15 (66.67%)
$8.13 (103.30%)
135
Hold Since 12-Sep-2022
$15
$8.67 (136.97%)
$29
3 years 4 months 15 days ago
(19-May-2023)
4/8 (50%)
$6.83 (83.60%)
86